16:45 EDT FDA converts Biogen Alzheimer’s treatment to full approval
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BIIB:
- Biogen, Eisai’s Alzheimer’s Drug Scores Big With FDA’s Full Approval
- FDA Grants Traditional Approval for LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer’s Disease
- Biogen announces new SPINRAZA data
- New Data at Cure SMA Highlight Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs After Gene Therapy
- Piper Sandler pharmaceuticals analysts to hold analyst/industry conference call